Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Raber

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer CenterT L Smith, J J Lee, H M Kantarjian, et al.
Cancer Research|March 15, 1992
Phase I trial and clinical pharmacology of elsamitrucinM N Raber, R A Newman, B M Newman, et al.
Cancer Investigation|January 1, 1990
Comprehensive criteria for assessing therapy-induced toxicityJ A Ajani, S R Welch, M N Raber, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesotheliomaH M Dhingra, W K Murphy, R J Winn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patientsJ L Abbruzzese, M C Abbruzzese, K R Hess, et al.
Investigational New Drugs|November 1, 1991
Phase I trial of FK973: description of a delayed vascular leak syndromeR Pazdur, D H Ho, K Daugherty, et al.
Anti-Cancer Drugs|February 1, 1992
Clinical pharmacokinetics of ifosfamide in combination with N-acetylcysteineJ A Benvenuto, W Ayele, S S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?R Lenzi, K R Hess, M C Abbruzzese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Unknown primary tumors metastatic to liverJ P Ayoub, K R Hess, M C Abbruzzese, et al.
Investigational New Drugs|February 1, 1991
Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neckD M Shin, A M Kramer, I W Dimery, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer CenterT L Smith, J J Lee, H M Kantarjian, et al.
Cancer Research|March 15, 1992
Phase I trial and clinical pharmacology of elsamitrucinM N Raber, R A Newman, B M Newman, et al.
Cancer Investigation|January 1, 1990
Comprehensive criteria for assessing therapy-induced toxicityJ A Ajani, S R Welch, M N Raber, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesotheliomaH M Dhingra, W K Murphy, R J Winn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patientsJ L Abbruzzese, M C Abbruzzese, K R Hess, et al.
Investigational New Drugs|November 1, 1991
Phase I trial of FK973: description of a delayed vascular leak syndromeR Pazdur, D H Ho, K Daugherty, et al.
Anti-Cancer Drugs|February 1, 1992
Clinical pharmacokinetics of ifosfamide in combination with N-acetylcysteineJ A Benvenuto, W Ayele, S S Legha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?R Lenzi, K R Hess, M C Abbruzzese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Unknown primary tumors metastatic to liverJ P Ayoub, K R Hess, M C Abbruzzese, et al.
Investigational New Drugs|February 1, 1991
Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neckD M Shin, A M Kramer, I W Dimery, et al.
Pageof 6